Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-8491
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia ; day:25 ; month:11 ; year:2021 ; pages:1-17
European archives of psychiatry and clinical neuroscience ; (25.11.2021), 1-17
- Creator
-
Stassen, H. H.
Bachmann, S.
Bridler, R.
Cattapan, K.
Herzig, D.
Schneeberger, A.
Seifritz, E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00406-021-01358-5
- URN
-
urn:nbn:de:101:1-2022020119153318046822
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stassen, H. H.
- Bachmann, S.
- Bridler, R.
- Cattapan, K.
- Herzig, D.
- Schneeberger, A.
- Seifritz, E.
- SpringerLink (Online service)
Other Objects (12)
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry
Tramp (detailing his day's work)
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry
Tramp (detailing his day's work)
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3180 students from Europe, the U.S., South America, and China
Cost of antipsychotic polypharmacy in the treatment of schizophrenia
Polypharmacy in schizophrenia - therapeutic option or a sign of despair?
Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations
Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
Polypharmacy in a hospitalized psychiatric population: risk estimation and damage quantification
Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy
Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan
Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry